학술논문

Low relapse risk in poor risk AML after conditioning with 10-day decitabine, fludarabine and 2 Gray TBI prior to allogeneic hematopoietic cell transplantation
Document Type
Article
Source
In: Bone Marrow Transplantation. (Bone Marrow Transplantation, August 2021, 56(8):1964-1970)
Subject
Language
English
ISSN
14765365
02683369